Effect of clarithromycin on sputum production and its rheological properties in chronic respiratory tract infections.
about
Macrolides for diffuse panbronchiolitisMacrolides for diffuse panbronchiolitisMacrolides for diffuse panbronchiolitisMacrolides for diffuse panbronchiolitisInhaled Antibiotics for Gram-Negative Respiratory InfectionsMacrolide immunomodulation of chronic respiratory diseases.Azithromycin treatment alters gene expression in inflammatory, lipid metabolism, and cell cycle pathways in well-differentiated human airway epithelia.Diffuse panbronchiolitis: role of macrolides in therapy.Diffuse panbronchiolitis in East Asia.Mechanisms of action and clinical application of macrolides as immunomodulatory medications.Genetic predisposition to diffuse panbronchiolitis.Anti-inflammatory effects of macrolides--an underappreciated benefit in the treatment of community-acquired respiratory tract infections and chronic inflammatory pulmonary conditions?Therapy with macrolides in patients with cystic fibrosis.Clarithromycin (Biaxin) extended-release tablet: a therapeutic review.Macrolides in chronic inflammatory skin disorders.Pathogen- and host-directed anti-inflammatory activities of macrolide antibioticsAzithromycin blocks quorum sensing and alginate polymer formation and increases the sensitivity to serum and stationary-growth-phase killing of Pseudomonas aeruginosa and attenuates chronic P. aeruginosa lung infection in Cftr(-/-) miceUpdate on antimicrobial agents: new indications of older agents.Treatment of chronic rhinosinusitis with low-dose, long-term macrolide antibiotics: an evolving paradigm.Combination therapy for airflow limitation in COPD.The role of airway secretions in COPD--clinical applications.Biotic acts of antibioticsRole of macrolide therapy in chronic obstructive pulmonary disease.Macrolides in the treatment of bronchiolitis obliterans in allograft recipients.Cellular and molecular biology of airway mucins.The role of N-acetylcysteine in the management of acute and chronic pulmonary complications of sulfur mustard: a literature review.Efficacy of concomitant administration of clarithromycin and acetylcysteine in bronchiolitis obliterans in seventeen sulfur mustard-exposed patients: An open-label study.Long-term azithromycin therapy in patients with severe COPD and repeated exacerbationsImmunomodulatory indications of azithromycin in respiratory disease: a concise review for the clinician.Effects of new quinolones on transepithelial electrical potential difference of tracheal mucosa in vivo.Effects of roxithromycin and erythromycin on interleukin 8-induced neutrophil recruitment and goblet cell secretion in guinea pig tracheas.Clarithromycin Suppresses Chloride Channel Accessory 1 and Inhibits Interleukin-13-Induced Goblet Cell Hyperplasia in Human Bronchial Epithelial CellsExploring the Role of CYP3A4 Mediated Drug Metabolism in the Pharmacological Modulation of Nitric Oxide Production.Clarithromycin inhibits overproduction of muc5ac core protein in murine model of diffuse panbronchiolitis.Azithromycin blocks neutrophil recruitment in Pseudomonas endobronchial infection.Low-dose clarithromycin therapy modulates CD4(+) T-cell responses in a mouse model of chronic Pseudomonas aeruginosa lung infection.
P2860
Q24186520-921BC033-3DFA-4A23-88A6-42CDD9448078Q24200544-5AD5605D-E491-43A9-83EE-AC84D59E753FQ24235571-63FE5497-953A-4489-8775-C30BFFCE5325Q24240570-6F5FB48A-EE50-457C-810E-FF9CA9E3CB9DQ28386160-2E201446-3327-4998-994B-4CFD460E7CDBQ33270407-850666CF-16D0-4AC2-BE91-C6857530D4E1Q33463373-4BC0BA1A-B676-4EBD-AFBE-1F1563895D62Q33844388-7D511146-F423-4728-81A1-D7D02C7314EFQ33844946-F313CCAC-4270-41A1-93BB-6BA98DF5BAE7Q33983140-358FAEB0-3132-4803-834C-ADAF0D2E6A60Q34025667-938E7548-4ACC-4BB8-862C-28CB35D9A1BAQ34375192-D6CD0AF0-C03D-4D0B-A7CD-069B93BD7711Q34523880-B753D6D7-4C33-4DBC-A62A-F3599A9FEBFBQ35917120-3BC94A5C-2B25-4024-AF78-41EEF696B091Q35997016-CEDAB504-0FBE-4F90-9E42-0162737A54C7Q36072425-AC2A0E98-8C35-4A5F-AF6D-E4DF85325E4FQ36095028-21437D8D-A91F-4766-A58D-30D046287AD7Q36222046-5254122F-3043-4941-948F-666B3363FA8EQ36282322-4EF22598-5626-48AB-B06A-26AF05B63441Q36445725-93326E2B-B9C2-4BBF-8ED5-33DBAC61E27DQ36674113-8143A89D-FC3E-4527-82FE-DD9A283625DDQ37101851-361ED3F4-29E4-4FAD-B934-F1665E85379EQ37319950-35D402EF-3A3D-43EF-8D32-33E368035812Q37476710-F96EA0F1-68F4-4BAA-AAD5-1DEE28280CEBQ38085109-5A1FBDE5-DFA2-45A5-B19D-139EE085BE9DQ38233230-60E10F45-645A-4FF7-8B76-4AFC5785B9CBQ38470747-1753D10F-0C8B-4133-BCF5-15EBBCE64A9EQ38624850-667246A9-AF21-4ED0-9F97-0AE29578ECEAQ39100345-7CAD6FFF-9948-4B85-A77E-A4F9C822150AQ39478629-C7DA2D63-8093-4A80-A9A3-9F85E8E739CCQ39782482-1129DFA8-945D-4B09-8C90-6D0535D9A814Q41537548-EDFD8C4B-EFFE-4935-A962-84316959B687Q42066416-4AF546A3-C9F0-4827-9322-CBAC0D3EE109Q44486010-F8814FE9-4CFA-409B-8173-7F9EE57D26BCQ45054229-94EF1F84-D79C-4322-9A13-BEE9A015DD11Q53180523-EB3DBA33-1A40-4820-BDD0-7B1B38BADDA4
P2860
Effect of clarithromycin on sputum production and its rheological properties in chronic respiratory tract infections.
description
1995 nî lūn-bûn
@nan
1995 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Effect of clarithromycin on sp ...... respiratory tract infections.
@ast
Effect of clarithromycin on sp ...... respiratory tract infections.
@en
type
label
Effect of clarithromycin on sp ...... respiratory tract infections.
@ast
Effect of clarithromycin on sp ...... respiratory tract infections.
@en
prefLabel
Effect of clarithromycin on sp ...... respiratory tract infections.
@ast
Effect of clarithromycin on sp ...... respiratory tract infections.
@en
P2093
P2860
P356
P1476
Effect of clarithromycin on sp ...... respiratory tract infections.
@en
P2093
P2860
P304
P356
10.1128/AAC.39.8.1688
P407
P577
1995-08-01T00:00:00Z